NCT07083635View on ClinicalTrials.gov

Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2026

Conditions
Menstruation DisturbancesMetrorrhagiaUterine HemorrhageContraception Behavior
Interventions
DRUG

Transdermal Ethinyl Estradiol/Norelgestromin Patch

Transdermal contraceptive patch containing ethinyl estradiol 600 micrograms and norelgestromin 6 milligrams per patch, manufactured by GEDEON RICHTER PLC and imported by Abbott.

DRUG

Placebo Patch

Identical-appearing transdermal patches without active hormonal ingredients , manufactured and imported by Convatec.

All Listed Sponsors
lead

Chulalongkorn University

OTHER